Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 147 for kidney and hypertension

Edit search filters
  1. Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant

    Rochester, MN

  2. A Study of the Benefits and Risks of Nulojix® (Belatacept)-Based Maintenance Immune Rejection Suppression for Kidney Transplant Recipients

    Scottsdale/Phoenix, AZ

  3. Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. A Study to Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients with Hyperoxaluria and Kidney Stones

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  5. Establishing the Safety and Effectiveness of Reloxaliase in Patients With Enteric Hyperoxaluria

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Acute Kidney Injury in Care Transitions (ACT) Trial

    Rochester, MN

  7. Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients (IMAGINE)

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study to Examine The Effectiveness, Feasibility, and Acceptability of Exercise Intervention on Frailty After Kidney Transplantation.

    Rochester, MN

  9. A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

    Jacksonville, FL, Rochester, MN

  10. Senescence in Chronic Kidney Disease

    Rochester, MN

.

Mayo Clinic Footer